Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FARICIMAB-SVOA vs FEBUXOSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FARICIMAB-SVOA vs FEBUXOSTAT: Safety Overview

Metric FARICIMAB-SVOA FEBUXOSTAT
Total FAERS Reports 1,908 5,843
Deaths Reported 175 404
Death Rate 9.2% 6.9%
Hospitalizations 169 1,755
Average Patient Age 73.5 yrs 66.7 yrs
% Female Patients 57.0% 31.6%
FDA Approval Date N/A Dec 19, 2023
Manufacturer N/A Novadoz Pharmaceuticals LLC
Route N/A ORAL
Marketing Status Prescription Prescription